Search

everythinglearnresearchcommunity

for

Search:↓

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Developing microRNA-based treatments is hard but has potential.

Newly made nicotinamide compounds could potentially treat cancer.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Ozenoxacin reduces sebum production, helping manage acne.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

miR-370-3p slows sheep hair cell growth by blocking SMAD4.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

Suppressing ODC activity reduces tumor growth in hair follicles.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

SUN11602 and ONO-1301 could help in skin healing and creating artificial skin.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Blocking Sonic Hedgehog signaling may help manage hair loss from chemotherapy.